Forte Biosciences Inc. buy krebskrebs
Start price
04.10.21
/
50%
€2.60
Target price
04.10.22
€5.00
Performance (%)
-58.69%
End price
05.10.22
€1.07
Summary
This prediction ended on 05.10.22 with a price of €1.07. Massive losses of -58.69% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Forte Biosciences Inc. | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% |
Comments by krebskrebs for this prediction
In the thread Tocagen diskutieren
Buy mit Kursziel 5,0
In the thread Trading Tocagen
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten